Classic i-Particles®
Learn more about the original
ABOUT US
Who we are
Adjuvatis develops, manufactures biocompatible delivery system called i-Particles® and proposes a formulation service based on its technology.
Our Mission
Providing scientists and pharmaceutical companies safer, more stable and effective formulations thanks to i-Particles® technology.
Our Advisory Board
Adjuvatis team is built around valuable experts, gathering insights into scientific orientations, business development and customer-dedicated marketing strategy.
Our Network
From extending our technological network to supporting innovation, Adjuvatis scientific partners widen our panel of expertise and contribute to strive for excellence.
TECHNOLOGY
Fully metabolizable i-Particles
i-Particles® technology originates from the fundamental statement that pharmaceuticals should never involve harmful by-products and only focus on patient safety. Starting from this idea, Adjuvatis technology is led by one main concept: safe-by-design.
i-Particles Technology
Synthetized by an eco-friendly and additive-free process, i-Particles® exclusively consist in a biodegradable polymer and selected active pharmaceutical ingredients.
Strategic solutions
Increasing pharmaceutical efficacy and safety while reducing risk profile and costs, and extending product life cycle.
Expertise
Following 10 years of research and supported by a multi-skilled team, Adjuvatis will push forward your active’s intrinsic properties and potentiate your product development.
APPLICATIONS
i-Particles - Driver of innovation
i-Particles® formulations have demonstrated enhancements in healthcare and technological fields, especially vaccines, antibody generation and drug delivery. Adjuvatis is constantly extending the scope of applications to reach new markets, support customer developments and prove once again the versatility of its technology.
02.
Antibody Generation
Reduce antibodies production costs and improve their affinity using i-Particles®.
03.
Drug Delivery System
Formulating with i-Particles® offer protection and sustained delivery for your active pharmaceutical ingredient.
PRODUCTS & SERVICES
i-Particles-based formulations & in-depth characterizations
Adjuvatis provides a full formulation development and characterization services in a rigorous quality framework.
INNOVATIVE RESEARCH
What are you waiting for?
Discover our fully dedicated and quality-oriented ways of working, integrating both skills and experience to provide cutting-edge service for formulation development of biopharmaceuticals.
DIRECT ACCESS
Meet Our Team
Our dynamic team, supported by a referent advisory board and external experts, qualifies for expertise in Chemistry, Biochemistry and Biology, Manufacturing and Partnering. By working collaboratively, we are committed to innovate for your therapeutic products developments.
Charlotte PRIMARD
PhD - CEO
Bernard VERRIER
PhD, Co-Founder - Scientific Referent
Bernard MANDRAND
PhD, Co-founder - Senior Consultant
David DA COSTA
MSc - Research Engineer
Maxime DZIKOWSKI
MSc - Manufacturing & Quality Control
Overcome technical obstacles and reach new markets.
OUR NETWORK
Expertise optimise us
Feel free to contact us to explore licensing opportunities, collaborative researches, or commercial partnerships.
LATEST NEWS
Adjuvatis Live
Follow our participation to scientific events, symposium and congresses.
Discover our press releases and publications.
Solubilization of an hydrophobic API for anti-cancer treatment
Poor water solubility is one of the most significant barrier limiting drug development. Indeed, more than 40% of compounds identified.
Read More 
A recombinant vaccine based on i-Particles is protective against H1N1 influenza infection
Recombinant Haemagglutinin Derived From the Ciliated Protozoan Tetrahymena thermophila Is Protective Against Influenza Infection Context Cilian AG (Germany), affiliated as.
Read More 
FASTCURE: a consortium of experts to respond to the epidemic COVID-19 coronavirus outbreak
FASTCURE is a consortium of experts for screening, identification and formulation of chemical compounds to combat SARS-CoV-2. Drug repurposing can.
Read More JOIN US
Welcome in Lyon
At the heart of the Biodistrict Lyon Gerland, a hotspot for world leaders in Life Sciences in vicinity to institutional, academic and private companies, Adjuvatis benefits from a unique environment in terms of technological innovation.
